Protocol CY 5021: A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients with Spinal Muscular Atrophy (SMA)
- Krosschell, Kristin (PD/PI)
Project: Research project
Project: Research project